SCHEMBL191204

SCHEMBL191204

Clc1cc(Sc2ccccc2Cl)ccn1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 1/20 0.44
GRM5 P41594 2/20 0.43
ALDH1A1 P00352 2/20 0.42
LMNA P02545 2/20 0.42
MAPT P10636 2/20 0.42
PKM P14618 1/20 0.42
KDM4E B2RXH2 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
HAO1 Q9UJM8 1/20 0.40
PRMT1 Q99873 1/20 0.40
TRPA1 O75762 1/20 0.40
FBP1 P09467 1/20 0.39
TDP1 Q9NUW8 2/20 0.38
KMT2A Q03164 1/20 0.38
LDHA P00338 1/20 0.37
LDHB P07195 1/20 0.37
HTT P42858 1/20 0.36
RORC P51449 1/20 0.36
RORB Q92753 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL191746 0.86 ALDH1A1 (0.40) HPGDGRM5ALDH1A1TRPA1
SCHEMBL191123 0.83 AR (0.41) HPGDGRM5ALDH1A1HAO1TRPA1
SCHEMBL190818 0.80 SIRT2 (0.44) GRM5ALDH1A1LMNAMAPTTRPA1
SCHEMBL191141 0.79 TRPA1 (0.47) HPGDGRM5ALDH1A1LMNAMAPT
SCHEMBL191108 0.79 ITGB2 (0.39) HPGDGRM5LMNATRPA1
SCHEMBL192450 0.79 AR (0.39) GRM5TRPA1
SCHEMBL190418 0.78 PKM (0.49) ALDH1A1LMNAPKMKDM4ETDP1
SCHEMBL31351866 0.77 HPGD (0.60) HPGDALDH1A1LMNAMAPTPKM
SCHEMBL192475 0.75 L3MBTL1 (0.61) HPGDGRM5ALDH1A1MAPTNPSR1
SCHEMBL2552028 0.74 NCF1 (0.38) HPGDGRM5ALDH1A1LMNAPKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1986645-B1 GLUCOKINASE ACTIVATORS ARRAY BIOPHARMA INC (US) 2012-01-04 EP disclosed
US-8022222-B2 Glucokinase activators ARRAY BIOPHARMA, INC. (US) 2011-09-20 US disclosed
US-20090247526-A1 GLUCOKINASE ACTIVATORS ARRAY BIOPHARMA INC. (US) 2009-10-01 US disclosed
CN-101437512-A Glucokinase activators ARRAY BIOPHARMA INC (US) 2009-05-20 CN disclosed
EP-1986645-A1 GLUCOKINASE ACTIVATORS Array Biopharma, Inc. (US) 2008-11-05 EP disclosed
WO-2007089512-A1 GLUCOKINASE ACTIVATORS ARRAY BIOPHARMA INC. (US) 2007-08-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090247526-A1 GLUCOKINASE ACTIVATORS GCKR, GCK, GALK1 HPGD 1204/4885GRM5 1123/4885ALDH1A1 1869/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.